Cargando…
Urinary chemerin as a potential biomarker for inflammatory bowel disease
PURPOSE: Systemic levels of the adipokine chemerin are elevated in different inflammatory conditions such as inflammatory bowel disease (IBD). In IBD, chemerin protein expression in colon mucosa is induced and serum chemerin levels are increased. Aim of this study was to identify chemerin protein in...
Autores principales: | Gunawan, Stefan, Elger, Tanja, Loibl, Johanna, Fererberger, Tanja, Sommersberger, Stefanie, Kandulski, Arne, Müller, Martina, Tews, Hauke Christian, Buechler, Christa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691457/ https://www.ncbi.nlm.nih.gov/pubmed/36438059 http://dx.doi.org/10.3389/fmed.2022.1058108 |
Ejemplares similares
-
Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
por: Tews, Hauke Christian, et al.
Publicado: (2023) -
Altered fecal bile acid composition in active ulcerative colitis
por: Sommersberger, Stefanie, et al.
Publicado: (2023) -
Fecal and Urinary Adipokines as Disease Biomarkers
por: Tews, Hauke C., et al.
Publicado: (2023) -
Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma
por: Feder, Susanne, et al.
Publicado: (2019) -
Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury
por: Peschel, Georg, et al.
Publicado: (2020)